Multiple Myeloma (MM) Withdrawn Phase 2 Trials for Panobinostat (DB06603)

Also known as: MULTIPLE MYELOMA (MM) / Multiple myeloma / Myeloma, Multiple / Multiple Myelomas / Multiple Myeloma(MM) / Plasma cell myelomas / Myelomatosis multiple / Peripheral plasma cell myeloma / Myelomatosis / Multiple myeloma myelomatosis / Plasma cell myeloma / Myeloma / Multiple myeloma with failed remission

DBCOND0040908 (Multiple Myeloma (MM))Withdrawn2 IdentifierTitlePurposeDrugs
NCT02756663Panobinostat in Combination With Carfilzomib and Dexamethasone in Relapsed or Relapsed and Refractory Multiple MyelomaTreatment